Medical Devices: Page 65
-
Getty Images
Alphatec buys robotic spine navigation system for $55M
The spine surgery specialist expects the robotic platform to begin generating revenue in 2025.
By Susan Kelly • Updated April 21, 2023 -
Getty Images
Lawsuit accuses J&J subsidiary of selling faulty knee replacements
A patient who had DePuy’s Attune knee system implanted, and then replaced when it loosened, claims the company downplayed the risks of the device.
By Elise Reuter • Updated April 21, 2023 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Permission granted by Abbott
Q&AFriday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
By Susan Kelly • April 21, 2023 -
Getty Images
Report names connected medical devices with the biggest cybersecurity risks
The findings come as medical device makers face upcoming FDA requirements for providing cybersecurity information as part of their pre-market submissions.
By Nick Paul Taylor • April 21, 2023 -
Courtesy of Nevro
Nevro names Hologic exec as CEO
Kevin Thornal will take the reins from current CEO D. Keith Grossman, who will retire next week.
By Elise Reuter • April 20, 2023 -
Courtesy of Abbott Laboratories
Abbott hit with FDA warning letter over unapproved changes to heart disease test
The FDA said that four changes made to the tests “could significantly affect the safety or effectiveness of the devices.”
By Nick Paul Taylor • Updated April 20, 2023 -
Courtesy of Fresenius
Fresenius flags fault with infusion system acquired last year in $240M deal
Fresenius noted a problem with the devices that can cause loss of power, potentially delaying or interrupting the supply of critical fluids and medications.
By Nick Paul Taylor • April 20, 2023 -
Permission granted by Johnson & Johnson
J&J study data show dramatic benefit to multiple myeloma cell therapy
A study abstract inadvertently posted online showed J&J and Legend’s therapy, Carvykti, reduced the risk of disease progression or death by more than 70% over standard drugs.
By Ned Pagliarulo • April 19, 2023 -
Medtronic says it plans more layoffs, declines to specify locations
The company said it began notifying some employees on Tuesday, but would not confirm the number of positions or locations of the jobs that would be cut.
By Elise Reuter • April 19, 2023 -
Permission granted by Abbott
Abbott boosts organic sales outlook as device demand accelerates
A rebound in surgical procedure volumes as hospital staffing improved at the start of the year partially offset a steep drop in COVID-19 testing sales.
By Susan Kelly • April 19, 2023 -
Getty Images
AFib study shows no effect on outcomes from 1-year delay of catheter ablation
Early treatment could be a boon for medtech companies such as Boston Scientific and Medtronic but is potentially challenging for healthcare systems. The new study suggests waits of up to a year will not harm patients.
By Nick Paul Taylor • April 19, 2023 -
VCG / Stringer via Getty Images
Intuitive posted 26% jump in robotic procedures in Q1 as hospitals chipped away at backlog
The company experienced “some backlog effect from patients generally returning to more normalized healthcare routines, given the effect of the pandemic over several years.”
By Nick Paul Taylor • April 19, 2023 -
Permission granted by Johnson & Johnson
J&J raises forecast as medtech procedures recover
The company’s medical device business grew by more than 7% in the first quarter.
By Elise Reuter • April 18, 2023 -
Getty Images
Post-approval modification of high-risk devices linked to 30% jump in recall risk: study
The authors suggest improved post-marketing surveillance systems may be needed to mitigate risks to patient safety.
By Nick Paul Taylor • April 18, 2023 -
Permission granted by Medtronic
What medtech startups need to know about remote monitoring
Four medtech executives talked about the future of hospital at home, and the difference between consumer devices and medical devices, in an event hosted by the Colorado Bioscience Association.
By Elise Reuter • April 17, 2023 -
Courtesy of LivaNova
LivaNova CEO quits as firm announces higher-than-expected preliminary earnings
Analysts from Needham and Stifel had opposite takes on how McDonald’s departure will affect the company, which has struggled in recent years to bring new products to market.
By Peter Green • April 17, 2023 -
Permission granted by Abbott
Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage
With a standalone reader, Abbott said it is working to make the FreeStyle Libre 3 system available to people covered by Medicare.
By Elise Reuter • April 17, 2023 -
Shutterstock/Lukasz Pawel Szczepanski
Sponsored by EsperOvercome the top 5 device management challenges of remote patient care with ease
As more organizations adopt RPM, they’re facing increasingly complex challenges managing, updating and securing their devices.
April 17, 2023 -
Getty Images
Proxy adviser backs diabetes device developer Sernova in fight against activist investors
Institutional Shareholders Services said the activist investors “failed to present a detailed explanation” of their case and recommended that shareholders vote for Sernova’s director nominees.
By Nick Paul Taylor • April 17, 2023 -
Permission granted by Medtronic
Q&AFriday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff
From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.
By Susan Kelly • April 15, 2023 -
Courtesy of Medtronic
Medtronic, 6 months after proposing patient monitoring spinoff, remains mum on separation plan
A standalone entity could achieve faster growth, even though recent spinoffs in the medtech sector have produced mixed results, analysts say.
By Susan Kelly • April 14, 2023 -
Courtesy of Philips
Fewer Philips replacement devices have reached patients than counted, FDA says
The agency raised concerns that the discrepancy could affect the estimated wait times for patients needing a replacement sleep apnea device.
By Elise Reuter • April 14, 2023 -
Courtesy of https://news.medtronic.com/newsroom-medtronic-hits-the-road-mobile-labs
Medtronic targets June closure of Epix facility, will lay off 59 employees
The company had bought Epix for a catheter-based, temperature-controlled cardiac ablation system designed to treat patients with irregular heartbeats.
By Nick Paul Taylor • April 14, 2023 -
Michael M. Santiago via Getty Images
Digital surgery firm Surgalign faces delisting by Nasdaq for shareholder equity noncompliance
The exchange has given Surgalign 45 days to submit a plan to regain compliance.
By Nick Paul Taylor • April 14, 2023 -
Courtesy of Walgreens
OTC hearing aid matches performance of audiologist-fitted device in small trial
People who used an over-the-counter hearing aid for six weeks saw similar results to people who used an audiologist-fitted device, suggesting less costly, self-fitted hearing aids could be an option.
By Nick Paul Taylor • April 13, 2023
Previous
